DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

FBI opens probe into alleged kickbacks by healthcare OEMs in Brazil Accused of making bribes to sell medical equipment

icometrix raises $18 million in funding Will help with deployment of icobrain software in Europe

Q&A with Michael Darling, VP Supply Chain, St. Luke’s Health System Discussing the clinical integration of supply chain

Consolidation, consumerism and telehealth are the top three industry trends for 2019 According to a wide sampling of 1,000 healthcare stakeholders

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

M&A trend lines in tech-enabled medical devices Connecting the dots on industry consolidation

Siemens' push to install Atellica systems may hurt full-year profits Still, Q2 growth 'clearly accelerated'

Radiology Partners and Banner Health team up to establish Banner Imaging Provides imaging services throughout the metro Phoenix area

M&A checklist: Get the most out of your time Buyer and seller trends for mergers and acquisitions

Air medical transportation: How a 15-minute ride may cost $30,000, and how we can change it Reducing sky-high transport expenses

Johnson & Johnson completes Auris Health deal

Thomas Dworetzky , Contributing Reporter
Johnson & Johnson's Ethicon has closed its deal to acquire Auris Health.

The acquisition, for nearly $3.4 billion in cash, could also include additional payments of up to $2.35 billion, if milestones are hit.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



The buy, which was anticipated to close in Q2 2019, adds privately held Auris Health's robotic platform technology to J&J's push to fight lung cancer and its digital surgery portfolio.

“We are focused on building a connected, data-driven digital ecosystem that pairs our market-leading surgical solutions with advanced technologies to improve the patient experience,” Ashley McEvoy, executive vice president, worldwide chair, Medical Devices at Johnson & Johnson, said in a statement, adding that Auris “will help us amplify the power of digital surgery to address unmet clinical needs and lead a transformation in surgical care and lung cancer intervention.”

Auris' efforts are currently centering around the treatment of lung cancer. Its Monarch platform is FDA-cleared for diagnostic and therapeutic bronchoscopic procedures.

The aim of the acquisition to “to simplify surgery, drive efficiency, reduce complications and improve outcomes for patients, ultimately making surgery safer,” said McEvoy when the deal was announced in February, adding that, “we believe the combination of best-in-class robotics, advanced instrumentation and unparalleled end-to-end connectivity will make a meaningful difference in patient outcomes.”

Auris founder and CEO Dr. Frederic Moll, who will join Johnson & Johnson, said in a statement at that time that becoming a part of the larger company would “help push the boundaries of what is possible in medical robotics and improve the lives of patients across the globe.”

The hope is that the deal will “dramatically accelerate our collective product innovation to develop new interventional solutions that redefine optimal patient outcomes,” he added.

The move should also contribute to the ongoing disruption of the medical innovation arena. “With Auris Health’s current focus on lung cancer, the Monarch Platform robotic technology will play an important role within the Lung Cancer Initiative at Johnson & Johnson, enabling the development of a differentiated digital solution that addresses key steps in the lung cancer care journey, from diagnosis to early stage intervention, that are central to the company’s commitment to develop solutions that prevent, intercept and cure this deadly disease,” according to the company.

The Auris technology will also be a boost to other Johnson & Johnson areas of interest, including open, laparoscopic, robotic and endoluminal surgical approaches – and fits in with other recent deals, including its acquisition in 2018 of Orthotaxy, a software-enabled surgery technology developer.

That deal gave the company access to proprietary technology in development for total and partial knee replacement.

It also fits in with J&J's partnership to develop the Verb Surgical Platform.

“We are very committed to our partnership with Verily on the development of the Verb Surgical Platform. Collectively, these technologies, together with our market-leading medical implants and solutions, create the foundation of a comprehensive digital ecosystem to help support the surgeon and patient before, during and after surgery,” said McEvoy.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2019 DOTmed.com, Inc.
版权所有